Randomized Phase 2/3 Trial of CpG Oligodeoxynucleotide PF-3512676 Alone or With Dacarbazine for Patients With Unresectable Stage III and IV Melanoma

J.S. Weber, H. Zarour, B. Redman, U. Trefzer, S. O'Day, A.J.M. van den Eertwegh, E. Marshall, S. Wagner

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)3944-3954
JournalCancer
Volume115
Issue number17
DOIs
Publication statusPublished - 2009

Cite this

Weber, J.S. ; Zarour, H. ; Redman, B. ; Trefzer, U. ; O'Day, S. ; van den Eertwegh, A.J.M. ; Marshall, E. ; Wagner, S. / Randomized Phase 2/3 Trial of CpG Oligodeoxynucleotide PF-3512676 Alone or With Dacarbazine for Patients With Unresectable Stage III and IV Melanoma. In: Cancer. 2009 ; Vol. 115, No. 17. pp. 3944-3954.
@article{59749b7f59b6463897510656460a047b,
title = "Randomized Phase 2/3 Trial of CpG Oligodeoxynucleotide PF-3512676 Alone or With Dacarbazine for Patients With Unresectable Stage III and IV Melanoma",
author = "J.S. Weber and H. Zarour and B. Redman and U. Trefzer and S. O'Day and {van den Eertwegh}, A.J.M. and E. Marshall and S. Wagner",
year = "2009",
doi = "10.1002/cncr.24473",
language = "Undefined/Unknown",
volume = "115",
pages = "3944--3954",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "17",

}

Randomized Phase 2/3 Trial of CpG Oligodeoxynucleotide PF-3512676 Alone or With Dacarbazine for Patients With Unresectable Stage III and IV Melanoma. / Weber, J.S.; Zarour, H.; Redman, B.; Trefzer, U.; O'Day, S.; van den Eertwegh, A.J.M.; Marshall, E.; Wagner, S.

In: Cancer, Vol. 115, No. 17, 2009, p. 3944-3954.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Randomized Phase 2/3 Trial of CpG Oligodeoxynucleotide PF-3512676 Alone or With Dacarbazine for Patients With Unresectable Stage III and IV Melanoma

AU - Weber, J.S.

AU - Zarour, H.

AU - Redman, B.

AU - Trefzer, U.

AU - O'Day, S.

AU - van den Eertwegh, A.J.M.

AU - Marshall, E.

AU - Wagner, S.

PY - 2009

Y1 - 2009

U2 - 10.1002/cncr.24473

DO - 10.1002/cncr.24473

M3 - Article

VL - 115

SP - 3944

EP - 3954

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 17

ER -